financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Maintains Buy Opinion On Shares Of Vistra Corp.
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Maintains Buy Opinion On Shares Of Vistra Corp.
Jun 23, 2025 10:24 PM

01:00 AM EDT, 06/24/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We raise our 12-month target by $35 to $215, 26.5x our 2026 EPS estimate (up $0.04 to $8.12; we cut our 2025 estimate by $0.57 to $5.74), above fully-regulated peers to reflect our strong growth expectations and our positive outlook for nuclear operators. We expect the $1.9B acquisition of ~2.6 GW of natural gas generation capacity from Lotus Infrastructure Partners will be accretive to its results, continuing a recent trend among power producers like Constellation Energy (CEG 315 ****) and NRG Energy (NRG 152 ***) seeking to grow their gas generation fleets during a period of rising electricity demand. Although not the "behind-the-meter" solution originally sought, we look favorably on the long-term PPA between Talen Energy (TLN 292 NR), AWS (AMZN 208 *****), and PPL Corporation (PPL 34 ***). According to Talen, the deal avoids the need for regulatory approval from FERC, and we think the creative solution could provide a useful model for other deals among data centers, utilities, and power generators.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Keeps Hold Opinion On Shares Of Darden Restaurants Inc
Research Alert: CFRA Keeps Hold Opinion On Shares Of Darden Restaurants Inc
Mar 24, 2025
02:15 PM EDT, 03/24/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month target by $16 to $216, 20x (from 19x) our FY 26 (May) EPS of $10.83 (from $10.50) and in line with its three-year historical average forward...
Research Alert: CFRA Raises Opinion On Shares Of Vf Corporation To Hold From Sell
Research Alert: CFRA Raises Opinion On Shares Of Vf Corporation To Hold From Sell
Mar 24, 2025
03:25 PM EDT, 03/24/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We maintain our 12-month price target of $19 is based on 15.2x our FY 26 (Mar.) EPS estimate and in line with the company's three-year average forward P/E multiple of...
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Alnylam Pharmaceuticals, Inc.
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Alnylam Pharmaceuticals, Inc.
Mar 24, 2025
04:45 PM EDT, 03/24/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our target price to $331 from $304 based on our Net Present Value (NPV) analysis. We lower our 2025 EPS estimate to -$1.62 from $0.30 our 2026 EPS...
Research Alert: CFRA Maintains Strong Sell Opinion On Shares Of Xpeng Inc.
Research Alert: CFRA Maintains Strong Sell Opinion On Shares Of Xpeng Inc.
Mar 24, 2025
01:35 PM EDT, 03/24/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We maintain our USD8 target (2x 2025 P/B) and Strong Sell rating on XPeng ( XPEV ). The company reported 2024 revenue growth of 33.2% to CNY40.87B, with gross margin...
Copyright 2023-2026 - www.financetom.com All Rights Reserved